Mr. Speaker, I thank the hon. Parliamentary Secretary to the Minister of Health for his comments. I am pleased to see—and I also noticed from his speech—that he is somewhat open. We simply do not see such clear and precise openness in the bill, but I am pleased to hear that this government is open to hearing from a variety of stakeholders in order to ensure that there will be no impact on the work currently being done in our academic and other institutions.
As we all know, the bill stipulates that a list of all users of these products would have to be submitted. What does that mean for a university? Does that mean all the students in the department, all the students who actually handle the substance or all the students who might walk through the hallways and common areas? These are additional questions that must be answered with the stakeholders and with the goodwill of all parliamentarians.
All these comments must be explored during the committee's study of the bill. I am delighted to see everyone coming together to ensure that this bill can be put in place while respecting current practices.